Deloitte China assists listing of Xunfei Healthcare on SEHK

Deloitte China supported the listing of Xunfei Healthcare Technology Co., Ltd. (Xunfei Healthcare, stock ticker: 02506.HK) on the Stock Exchange of Hong Kong (SEHK) on 30 December 2024. Xunfei Healthcare is the only company that had China Securities Regulatory Commission's notification for an overseas spin-off listing from an A-share listed company this year, and Hong Kong's 1st IPO for a healthcare Large Language Model developer.

Xunfei Healthcare offered about 7.04 million shares at HKD82.8 each, raising around HKD583 million.

(From Left) Melinda Wu, Deloitte China’s Audit and Assurance (A&A) manager; Vicky Zhang, Deloitte China’s A&A associate director; Alvin Tse, Eastern Region Hong Kong Offering Leader of the Deloitte China Capital Market Services Group; Xiaodong Tao, General Manager and Executive Director of Xunfei Healthcare; Kurt Tan, Deloitte China's chief growth officer; Angelina Ju, A&A partner, and Young Xu, A&A manager attend the listing ceremony of Xunfei Healthcare(From Left) Vicky Zhang, Melinda Wu, Kurt Tan, Wei Liu, Secretary of the Board of Directors of Xunfei Healthcare, Xiaodong Tao, Jinping Qian, Chief Financial Officer of Xunfei Healthcare, Angelina Ju; Alvin Tse, and Young Xu attend Xunfei Healthcare’s listing ceremony

(From Left) Vicky Zhang, Melinda Wu, Kurt Tan, Wei Liu, Secretary of the Board of Directors of Xunfei Healthcare,  Xiaodong Tao, Jinping Qian, Chief Financial Officer of Xunfei Healthcare,  Angelina Ju; Alvin Tse, and Young Xu attend Xunfei Healthcare’s listing ceremony

Client overview

Xunfei Healthcare is an AI-empowered healthcare solution provider, offering products and solutions that support a range of healthcare services, ranging from health risk warnings, early screening, auxiliary diagnosis and treatment as well as treatment effect evaluation to post-discharge management and chronic disease management. The company has independently developed AI technologies that underpin their products and solutions.

Source: Xunfei Healthcare’s IPO prospectus published on 18 December 2024

Deloitte’s role

As one of the core service institutions, Deloitte China has been deeply involved in the entire process of offering reporting, fundraising and listing of for this IPO. Our engagement team maintained a dedicated and focused attitude with a high-quality philosophy of diligence and excellence. We delivered the highest quality of professional services using our rich industry experience to assist Xunfei Healthcare to complete its filing work smoothly at every stage of Iisting. We also cooperated with all related professional parties to achieve the Xunfei Healthcare's listing on SEHK.

Deloitte China congratulates Xunfei Healthcare on its successful listing on SEHK. We will continue to provide high quality professional services and outstanding resources integration to assist more clients to take one-step ahead in today's increasingly competitive and complex business environment.